Business Update
During the third quarter of 2026, ENDRA continued to manage its operating costs while continue to develop its third-generation ultrasound product. At the same time, ENDRA is working to advance its proposed merger with
Pursuant to the merger agreement announced on
Completion of the transaction remains subject to customary closing conditions, including stockholder approvals, effectiveness of the registration statement on Form S-4, and compliance with applicable Nasdaq listing requirements.
Management Commentary
“Our focus during the third quarter remained on completing the proposed merger with Noble Africa while managing ENDRA's operating resources and liquidity to support transaction-related priorities,” said
“The proposed transaction represents an important strategic opportunity for our stockholders. We continue to work with our merger counterparties to complete the remaining steps necessary to close the merger.”
Third Quarter 2026 Financial Results
Cash used in operations during the third quarter of 2026 was
Operating expenses in the third quarter of 2026 were
The net loss for the third quarter of 2026 was
As of
About
Important Additional Information and Where to Find It
This press release relates to the proposed merger and related transactions (the “Proposed Transactions”) involving ENDRA,
Investors and stockholders will be able to obtain free copies of the Form S-4, the Proxy Statement and other documents filed by ENDRA and
Participants in the Solicitation
ENDRA,
No Offer or Solicitation
This press release is not intended to and does not constitute a solicitation of a proxy, consent or approval with respect to any securities or in respect of the Proposed Transactions or an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities pursuant to the Proposed Transactions or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law, or an exemption therefrom. Subject to certain exceptions to be approved by the relevant regulators or certain facts to be ascertained, the public offer will not be made directly or indirectly, in or into any jurisdiction where to do so would constitute a violation of the laws of such jurisdiction, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce, or any facility of a national securities exchange, of any such jurisdiction.
Forward-Looking Statements
All statements in this press release that are not based on historical fact are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements—based on certain assumptions and describing our future plans, strategies, and expectations—can generally be identified by the use of terms such as “approximate,” “anticipate,” “attempt,” “believe,” “can,” “could,” “estimate,” “expect,” “forecast,” “future,” “goal,” “hope,” “intend,” “may,” “plan,” “possible,” “potential,” “project,” “seek,” “should,” “will,” “would,” or other comparable terms (including the negative of any of the foregoing), although some forward-looking statements are express differently. Each forward-looking statement contained in this release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement.
Applicable risks and uncertainties include, among others: the risk that the conditions to the closing or consummation of the proposed merger with Noble Africa and related transactions (the “Proposed Transactions”) are not satisfied, including the failure to timely obtain approval of the Proposed Transactions from ENDRA stockholders, if at all; the risk that the proposed financings are not completed in a timely manner, if at all; uncertainties as to the timing of the consummation of the Proposed Transactions and the ability of each of ENDRA and Noble Africa to consummate the Proposed Transactions; risks related to ENDRA’s continued listing on Nasdaq until closing of the Proposed Transactions and the combined company’s ability to remain listed following the closing of the Proposed Transactions; risks related to ENDRA’s ability to correctly estimate its operating expenses and its expenses associated with the Proposed Transactions, pending the closing of the Proposed Transactions, as well as uncertainties regarding the impact any delay in the closing would have on the anticipated cash resources of ENDRA, and other events and unanticipated spending and costs that could reduce ENDRA’s cash resources; risks related to the failure or delay in obtaining required approvals from any governmental or quasi-governmental entity necessary to consummate the Proposed Transactions; the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the merger agreement; the effect of the announcement or pendency of the Proposed Transactions on ENDRA’s or Noble Africa’s business relationships, operating results and business generally; costs related to the Proposed Transactions; risks related to the market price of ENDRA’s common stock relative to the value suggested by the Proposed Transactions; the outcome of any legal proceedings that may be instituted against ENDRA, Noble Africa or any of their respective directors, managers, or officers related to the Proposed Transactions; costs of the Proposed Transactions and unexpected costs, charges or expenses resulting from the Proposed Transactions; changes in regulatory requirements and government incentives; risks associated with the possible failure to realize, or that it may take longer to realize than expected, certain anticipated benefits of the Proposed Transactions, including with respect to future financial and operating results, legislative, regulatory, political and economic developments, and those uncertainties and factors; and the risk of involvement in litigation, including securities class action litigation, that could divert the attention of the management of ENDRA or the combined company, harm the combined company’s business and may not be sufficient for insurance coverage to cover all costs and damages, expectations regarding our treasury strategy and our ability to execute it successfully; our limited commercial experience, limited cash resources, and history of losses; our ability to obtain adequate financing to fund operations in the future; our ability to regain and maintain compliance with Nasdaq listing standards; delays or changes in regulatory requirements, policies, or guidelines; the repeatability of clinical results across larger trial populations; potential delays in submitting required regulatory applications or other submissions to, or receiving approvals from, the
You should not rely on forward-looking statements as predictions of future events. Forward-looking statements in this press release speak only as of the date of issuance, and ENDRA assumes no obligation to update such statements to reflect actual results or changes in expectations, except as required by law.
| ||||||||
|
|
| ||||||
|
|
| 2026 |
|
|
| 2025 |
|
Assets |
| (Unaudited) |
|
| ||||
|
|
|
|
| ||||
Current Assets |
|
|
|
| ||||
Cash |
| $ | 1,516,523 |
|
| $ | 762,365 |
|
Restricted cash |
|
| 3,425,003 |
|
|
| - |
|
Prepaid expenses |
|
| 109,590 |
|
|
| 205,604 |
|
Total Current Assets |
|
| 5,051,116 |
|
|
| 967,969 |
|
Non-Current Assets |
|
|
|
| ||||
Fixed assets, net |
|
| 35,603 |
|
|
| 42,516 |
|
Right of use assets |
|
| 368,903 |
|
|
| 461,949 |
|
Prepaid expenses, long term |
|
| - |
|
|
| 365,417 |
|
Digital Assets |
|
| 1,261,490 |
|
|
| 2,009,960 |
|
Other assets |
|
| 5,986 |
|
|
| 5,986 |
|
Total Assets |
| $ | 6,723,098 |
|
| $ | 3,853,797 |
|
|
|
|
|
| ||||
Liabilities and Stockholders’ Equity |
|
|
|
| ||||
Current Liabilities |
|
|
|
| ||||
Accounts payable and accrued liabilities |
| $ | 492,272 |
|
| $ | 621,578 |
|
Lease liabilities, current portion |
|
| 143,452 |
|
|
| 129,378 |
|
Total Current Liabilities |
|
| 635,724 |
|
|
| 750,956 |
|
|
|
|
|
| ||||
Long Term Liabilities |
|
|
|
| ||||
Lease liabilities |
|
| 253,085 |
|
|
| 362,974 |
|
Warrant Liability |
|
| 632,475 |
|
|
| 479,747 |
|
Total Long Term Liabilities |
|
| 885,560 |
|
|
| 842,721 |
|
|
|
|
|
| ||||
Total Liabilities |
|
| 1,521,284 |
|
|
| 1,593,677 |
|
Commitments and Contingencies |
|
| - |
|
|
| - |
|
|
|
|
|
| ||||
Stockholders’ Equity |
|
|
|
| ||||
Series A Convertible Preferred Stock, |
|
| - |
|
|
| - |
|
Series B Convertible Preferred Stock, |
|
| - |
|
|
| - |
|
Series C Convertible Preferred Stock, |
|
| - |
|
|
| - |
|
Common stock, |
|
| 148 |
|
|
| 116 |
|
Additional paid in capital |
|
| 118,356,529 |
|
|
| 112,725,513 |
|
Receivable related to employee equity awards |
|
| (9,337 | ) |
|
| - |
|
Accumulated deficit |
|
| (113,145,526 | ) |
|
| (110,465,509 | ) |
Total Stockholders’ Equity |
|
| 5,201,814 |
|
|
| 2,260,120 |
|
Total Liabilities and Stockholders’ Equity |
| $ | 6,723,098 |
|
| $ | 3,853,797 |
|
| ||||||||||||||||
|
| Three Months |
| Three Months |
| Nine Months |
| Nine Months | ||||||||
|
|
|
|
| ||||||||||||
|
|
| 2026 |
|
|
| 2025 |
|
|
| 2026 |
|
|
| 2025 |
|
Operating Expenses |
|
|
|
|
|
|
|
| ||||||||
Research and development |
| $ | 176,280 |
|
| $ | 432,113 |
|
| $ | 1,186,355 |
|
| $ | 1,341,859 |
|
Sales and marketing |
|
| - |
|
|
| 45,285 |
|
|
| 10,091 |
|
|
| 183,110 |
|
General and administrative |
|
| 1,538,883 |
|
|
| 893,305 |
|
|
| 4,175,721 |
|
|
| 2,616,106 |
|
Total operating expenses |
|
| 1,715,163 |
|
|
| 1,370,703 |
|
|
| 5,372,167 |
|
|
| 4,141,075 |
|
|
|
|
|
|
|
|
|
| ||||||||
Operating loss |
|
| (1,715,163 | ) |
|
| (1,370,703 | ) |
|
| (5,372,167 | ) |
|
| (4,141,075 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Other Income (Expenses) |
|
|
|
|
|
|
|
| ||||||||
Other income (expense) |
|
| (28 | ) |
|
| 42,018 |
|
|
| 278 |
|
|
| 79,474 |
|
Digital asset staking compensation |
|
| 778 |
|
|
| - |
|
|
| 21,538 |
|
|
| - |
|
Unrealized gain on change in fair value of digital assets |
|
| 168,049 |
|
|
| - |
|
|
| 2,197,117 |
|
|
| - |
|
Realized gain on change in fair value of digital assets |
|
| 341,872 |
|
|
| - |
|
|
| 872,812 |
|
|
| - |
|
Digital asset management and performance fees |
|
| (246,867 | ) |
|
| - |
|
|
| (246,867 | ) |
|
| - |
|
Changes in fair value of warrant liability |
|
| (77,169 | ) |
|
| (267,274 | ) |
|
| (152,728 | ) |
|
| 203,400 |
|
Total other income/(expense) |
|
| 186,635 |
|
|
| (225,256 | ) |
|
| 2,692,150 |
|
|
| 282,874 |
|
|
|
|
|
|
|
|
|
| ||||||||
Income/(loss) from operations before income taxes |
|
| (1,528,528 | ) |
|
| (1,595,959 | ) |
|
| (2,680,017 | ) |
|
| (3,858,201 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Provision for income taxes |
|
| - |
|
|
| - |
|
|
| - |
|
|
| - |
|
|
|
|
|
|
|
|
|
| ||||||||
Net Income (Loss) |
| $ | (1,528,528 | ) |
| $ | (1,595,959 | ) |
| $ | (2,680,017 | ) |
| $ | (3,858,201 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Net income (loss) per share – basic and diluted |
| $ | (1.02 | ) |
| $ | (2.10 | ) |
| $ | (2.00 | ) |
| $ | (5.68 | ) |
|
|
|
|
|
|
|
|
| ||||||||
Weighted average common shares – basic and diluted |
|
| 1,499,838 |
|
|
| 761,218 |
|
|
| 1,342,470 |
|
|
| 679,210 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20261116500276/en/
Company Contact:
Investor Relations
investors@endrainc.com
www.endrainc.com
Investor Relations Contact:
Alliance Advisors IR
973-873-7724
vcervantes@allianceadvisors.com
Source: